Securities code: 600781 securities abbreviation: St Furen Announcement No.: 2022-002 Furen Group Pharmaceutical Co.Ltd(600781)
Announcement on the judicial auction and transfer of some shares of the controlling shareholder of the company
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Furen Group Pharmaceutical Co.Ltd(600781) (hereinafter referred to as "the company") recently learned through the Alibaba auction system of Taobao and zhongdeng that 9 million shares held by the controlling shareholder Furen Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Furen group") have been auctioned and the transfer registration procedures have been completed. The specific information is as follows: I. Basic information of this judicial auction
In the case of the dispute over the loan contract between Henan pozhipin Trading Co., Ltd., the applicant for enforcement, and Furen Pharmaceutical Group Co., Ltd., Furen Technology Holdings (Beijing) Group Co., Ltd., Furen Group Pharmaceutical Co.Ltd(600781) and Zhu Wenchen, the Zhengzhou intermediate people's court executed the ruling (2019) yu01 Zhibao No. 260 in the process of litigation, The restricted tradable shares of the company held by the executee Furen group (Securities Account No.: b881047504) were frozen. In accordance with articles 244 and 247 of the Civil Procedure Law of the people's Republic of China, Zhengzhou intermediate people's court ruled to evaluate and auction the 9 million restricted circulating shares and fruits of the company held by the enforced Furen group, and auctioned them through the Taobao judicial auction network platform on September 28, 2021. On September 29, 2021, the buyer Beijing Jiutai e-commerce Co., Ltd. won the auction target at a price of 22047000 yuan. According to industrial and commercial information, Dongfang daodu (Beijing) Cultural Industry Development Co., Ltd., the single controlling shareholder of Beijing Jiutai e-commerce Co., Ltd., was a subsidiary of Furen Pharmaceutical Group Co., Ltd. from October 19, 2014 to January 11, 2018, Furen Pharmaceutical Group Co., Ltd. transferred the equity of Dongfang daodu company to Henan Furen Holding Co., Ltd. on March 5, 2021, Henan Furen Holding Co., Ltd. transferred the equity of Dongfang daodu company to Shanghai Jingyi Trading Co., Ltd. so far, Beijing Jiutai e-commerce Co., Ltd. is no longer associated with the controlling shareholder.
The completion of this equity transfer will not lead to changes in the controlling shareholder or actual controller of the company.
2、 Cumulative freezing of controlling shareholders' shares
As of the disclosure date of the announcement, the cumulative frozen shares of the controlling shareholders and their persons acting in concert are as follows:
Shareholder's name, number of shares held, shareholding ratio accumulated frozen, proportion of shares held in the total number of shares of the company
Furen Pharmaceutical Group 6735888110.74% 67358881100% 10.74% Co., Ltd
Note: Furen group holds 67358881 shares of the company, including 38539326 restricted shares and 28819555 unlimited shares.
3、 Other information of controlling shareholders
1. Up to now, the overdue debt of Furen group is estimated to be about 6.631 billion yuan. Due to overdue debts, Furen group faces several lawsuits involving an amount of about 6.6 billion yuan, and the specific amount needs to be further verified.
2. Up to now, the company has provided the controlling shareholder and its related parties with a loan balance of 1687728100 yuan after repaying the amounts owed to the controlling shareholder and its related parties; The company provided 2479653100 yuan of joint and several liability guarantee to the controlling shareholders and related parties, and the remaining guarantee balance was 1746951700 yuan. The above matters constitute the fund occupation and illegal guarantee of related parties, which is expected to be unresolved within one month.
3. The judicial auction of the controlling shareholder's shares will not have an impact on the company's control, ownership structure and corporate governance.
The information disclosure newspapers designated by the company are Shanghai Securities News, China Securities News, securities times and Securities Daily, and the information disclosure website is www.sse.com of Shanghai Stock Exchange com.. cn.， The information released by the company shall be subject to the announcement information published in the above designated newspapers and websites. The company will timely disclose the information in strict accordance with the provisions and requirements of relevant laws and regulations. Please pay attention to the investment risks. It is hereby announced.
Furen Group Pharmaceutical Co.Ltd(600781) board of directors January 7, 2020
